Jeremy Barton

The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients

Jill Hallin, Lars D. Engstrom, Lauren Hargis et al. · Cancer Discovery · 2019 · 1.2K citations · Full text

Large-Area Nanoscale Patterning:  Chemistry Meets Fabrication

Joel Henzie, Jeremy Barton, Christopher L. Stender et al. · Accounts of Chemical Research · 2006 · 212 citations

Engineering, Nanostructured Surface, Pattern Transfer +16

A phase 1 multidose study of SGN-30 immunotherapy in patients with refractory or recurrent CD30+ hematologic malignancies

Nancy L. Bartlett, Anas Younes, Matthew Carabasi et al. · Blood · 2007 · 196 citations · Full text

Tetrahedral Zinc Blende Tin Sulfide Nano‐ and Microcrystals

Eric C. Greyson, Jeremy Barton, Teri W. Odom · Small · 2006 · 192 citations

Materials Science, Chemical Engineering, Engineering +11

A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer

Katherine M. Bell‐McGuinn, Carolyn M. Matthews, Steffan N. Ho et al. · Gynecologic Oncology · 2011 · 164 citations

Single-arm Study, Phase Ii, Medicine +8